Pathogenicity Levels of Colombian Strains of Candida auris and Brazilian Strains of Candida haemulonii Species Complex in Both Murine and Galleria mellonella Experimental Models
Open Access
- 10 July 2020
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 6 (3) , 104
Abstract
Candida auris and Candida haemulonii complex (C. haemulonii, C. haemulonii var. vulnera and C. duobushaemulonii) are phylogenetically related species that share some physiological features and habits. In the present study, we compared the virulence of these yeast species using two different experimental models: (i) Galleria mellonella larvae to evaluate the survival rate, fungal burden, histopathology and phagocytosis index and (ii) BALB/c mice to evaluate the survival. In addition, the fungal capacity to form biofilm over an inert surface was analyzed. Our results showed that in both experimental models, the animal survival rate was lower when infected with C. auris strains than the C. haemulonii species complex. The hemocytes of G. mellonella showed a significantly reduced ability to phagocytize the most virulent strains forming the C. haemulonii species complex. Interestingly, for C. auris, it was impossible to measure the phagocytosis index due to a general lysis of the hemocytes. Moreover, it was observed a greater capability of biofilm formation by C. auris compared to C. haemulonii species complex. In conclusion, we observed that C. auris and C. haemulonii complex have different levels of pathogenicity in the experimental models employed in the present study.Keywords
This publication has 39 references indexed in Scilit:
- New Clonal Strain ofCandida auris, Delhi, IndiaEmerging Infectious Diseases, 2013
- Epidemiology of Candidemia in Latin America: A Laboratory-Based SurveyPLOS ONE, 2013
- Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic YeastsJournal of Clinical Microbiology, 2012
- Echinocandin Resistance in Two Candida haemulonii Isolates from Pediatric PatientsJournal of Clinical Microbiology, 2012
- Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesianain the control of experimental candidiasisBMC Microbiology, 2012
- Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomesInternational Journal of Antimicrobial Agents, 2010
- Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical FeaturesClinical Infectious Diseases, 2009
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospitalMicrobiology and Immunology, 2009
- A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testingNature Protocols, 2008
- Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and FluconazoleJournal of Clinical Microbiology, 2007